## AXON: Axon Enterprise, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -1.1% below STRENGTH zone (3.0-6.0%); PEG 2.86 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($492.95)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Norges Bank Invests $637.81 Million in Axon Enterprise, Inc $AXON**
- Source: MarketBeat | 20251201T113613 | Somewhat-Bullish | Relevance: 100%
- Norges Bank initiated a new position in Axon Enterprise, Inc. ($AXON) during the second quarter, purchasing 770,353 shares valued at approximately $637.81 million, giving it a 0.98% stake. The investment comes as Axon reported a 30.6% revenue increase but missed EPS expectations, while analysts maintain a "Moderate Buy" rating with an average target price of $814.00. Insider selling of 38,622 shares ($26.44 million) has also been noted in the last 90 days.

**2. Schroder Investment Management Group Purchases 3,914 Shares of Axon Enterprise, Inc $AXON**
- Source: MarketBeat | 20251202T120415 | Somewhat-Bullish | Relevance: 99%
- Schroder Investment Management Group increased its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 5.1% in Q2 2025, purchasing 3,914 additional shares to hold a total of 79,985 shares valued at approximately $66.2 million. Other institutional investors also significantly increased their positions, while company insiders, including the CEO and CFO, sold shares during the last quarter. Analysts maintain a "Moderate Buy" consensus rating for Axon, despite the company missing EPS estimates but reporting a 30.6% increase in revenue year-over-year.

**3. Axon Enterprise, Inc $AXON Shares Sold by XTX Topco Ltd**
- Source: MarketBeat | 20251130T132101 | Neutral | Relevance: 99%
- XTX Topco Ltd decreased its stake in Axon Enterprise, Inc. by 58.5% in the second quarter, selling 2,421 shares and retaining 1,714 shares valued at approximately $1.419 million. This occurred as Axon missed quarterly EPS estimates but saw a 30.6% revenue increase year-over-year. Insider selling has amounted to $26.4 million over the past three months, while institutional ownership remains high at 79.08%, with analysts giving an average "Moderate Buy" rating and an $814 target.

**4. Skandinaviska Enskilda Banken AB publ Sells 1,057 Shares of Axon Enterprise, Inc $AXON**
- Source: MarketBeat | 20251201T115045 | Neutral | Relevance: 99%
- Skandinaviska Enskilda Banken AB publ reduced its stake in Axon Enterprise, Inc. by 6.6%, selling 1,057 shares in the second quarter and ending with 14,874 shares valued at approximately $12.31 million. Other institutional investors also adjusted their positions in AXON, with the stock currently 79.08% owned by hedge funds and institutions. Axon's Q3 revenue rose 30.6% year-over-year but missed EPS estimates, while analysts maintain a "Moderate Buy" consensus with a target price of $814.00.

**5. Dilation Capital Management LP Invests $3.81 Million in Axon Enterprise, Inc $AXON**
- Source: MarketBeat | 20251201T095218 | Neutral | Relevance: 99%
- Dilation Capital Management LP has acquired a new stake of 4,607 shares in Axon Enterprise, Inc, valued at approximately $3.81 million, making it their 19th largest holding. Axon missed Q2 EPS estimates but saw a 30.6% revenue increase, and analysts maintain a "Moderate Buy" rating despite recent price target cuts. Insider transactions show recent stock sales by a director and the CEO.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-17 | RBC Capital | $860 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-17 | RBC Capital | init | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 6 ($0.00M) |
| Sells | 16 ($28.13M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 11.8% (+4.2%)
- Blackrock Inc.: 10.4% (+8.3%)
- State Street Corpora: 4.3% (+6.4%)
- FMR, LLC: 3.8% (+2.1%)
- Geode Capital Manage: 2.8% (+5.7%)

### Key Risks

1. Heavy insider selling: $28M sold (16 transactions in 90 days).
2. Valuation risk: PEG 2.9x with declining EPS estimates leaves no margin for error.
3. Long-term trend broken: trading 20.6% below SMA200.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.86 signals overvaluation risk, limited margin of safety. Forward P/E 71.3x stretched relative to 19% growth. Balance sheet: strong liquidity (3.1x). Revenue growth strong at 25% YoY. Insider selling cluster ($28.1M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $44.9B |
| Beta | 1.40 |
| 52W Range | $469.24 - $885.92 |
| Short Interest | 2.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.86 |
| Forward P/E | 71.3 |
| Current P/E | 85.1 |
| YoY Growth | 19.4% |
| EPS Direction | FALLING |

### Technicals

MRS_10 strengthening from -3.1% to -1.1% (+2.0% in 5 days), confirming momentum buildup. Below STRENGTH zone by 4.1pp (needs >3.0% for momentum thesis). Below SMA200 (0.79x), long-term trend not supportive. MACD histogram positive (3.57), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.07% (CS: 54) | Neutral |
| RSI_14 | 31.4 | Neutral |
| MACD Histogram | 3.57 | Bullish |
| vs SMA20 | 0.958x | Below |
| vs SMA50 | 0.823x | Below |
| vs SMA200 | 0.794x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $537.75
- **Stop Loss:** $492.95 (8.3% risk)
- **Target:** $582.55 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 11
- **Position Value:** $5,915.25
- **Portfolio %:** 5.92%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-02-24 (Est: $1.60)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.54 | $1.17 | -24.1% |
| 2025Q2 | $1.46 | $2.12 | +45.0% |
| 2025Q1 | $1.28 | $1.41 | +10.2% |
| 2024Q4 | $1.40 | $2.08 | +48.2% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*